Tubular expression of intercellular adhesion molecule-1 during renal allograft rejection

Transplantation

Volumn 48, Issue 2, 1989, Pages 226-230

  Faull, Randall J ^a,b   Russ, Graeme R ^b  

^a NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE ANTIGEN;

ANTIGEN EXPRESSION; GRAFT REJECTION; HISTOLOGY; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL;

ANTIGENS, SURFACE; BIOPSY; CELL ADHESION; CELL ADHESION MOLECULES; GRAFT REJECTION; HLA-D ANTIGENS; HUMAN; IMMUNOENZYME TECHNIQUES; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; SUPPORT, NON-U.S. GOV'T;

EID: 0024410504     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-198908000-00009     Document Type: Article

References (30)

1. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987; 48: 549.
2. Boyd AW, Wawryk SO, Burns GF, Fecondo JV. Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms. Proc Natl Acad Sci USA 1988; 85: 3095.
3. Martz E. LFA-1 and other accessory molecules functioning in adhesions of T and B lymphocytes. Hum Immunol 1987; 18: 3.
4. Haskard D, Cavender D, Beatty P, Springer T, Ziff M. T lymphocyte adhesion to endothelial cells: mechanisms demonstrated by anti-LFA-1 monoclonal antibodies. J Immunol 1986; 137: 2901.
5. Mentzer SJ, Burakoff SJ, Faller DV. Adhesion of T lymphocytes to human endothelial cells is regulated by the LFA-1 membrane molecule. J Cell Physiol 1986; 126: 285.
6. Wallis WJ, Beatty PG, Ochs HD, Harlan JM. Human monocyte adherence to cultured vascular endothelium: monoclonal antibody- defined mechanisms. J Immunol 1985; 135: 2323.
7. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987; 84: 9238.
8. Springer TA, Dustin ML, Kishimoto TK, Marlin SD. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol 1987; 5: 223.
9. Selvaraj P, Plunkett ML, Dustin M, Sanders ME, Shaw S, Springer TA. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3. Nature 1987; 326: 400.
10. Krensky AM, Sanchez-Madrid F, Robbins E, Nagy JA, Springer TA, Burakoff SJ. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol 1983; 131: 611.
11. Sanchez-Madrid F, Krensky AM, Ware CF, et al. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci USA 1982; 79: 7489.
12. Pohlman TH, Stanness KA, Beatty PG, Ochs HD, Harlan JM. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-a increases neutrophil adherence by a CDwl8-dependent mechanism. J Immunol 1986; 136: 4548.
13. Sanchez-Madrid F, Nagy JA, Robbins E, Simon P, Springer TA. A human leukocyte differentiation antigen family with distinct «-subunits and a common 0-subunit. J Exp Med 1983; 158: 1785.
14. Rothlein R, Dustin ML, Marlin SD, Springer TA. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 1986; 137: 1270.
15. Marlin SD, Springer TA. Purified intercellular adhesion molecule- 1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987; 51: 813.
16. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-7 : tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245.
17. Pober JS, Gimbrone MA, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986; 137: 1893.
18. Hall BM, Bishop GA, Duggin GG, Horvath JS, Philips J, Tiller DJ. Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet 1984; 2: 247.
19. Halloran PF, Autenried P, Wadgymar A. Regulation of HLA expression in human kidney. Clin Immunol Allergy 1986; 6: 411.
20. Pober JS, Collins T, Gimbrone MA, Libby P, Reiss CS. Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation 1986; 41: 141.
21. Pober JS, Gimbrone MA, Cotran RS, et al. Ia expression by vascular endothelium is inducible by activated T cells and by human 7 interferon. J Exp Med 1983; 157: 1339.
22. Hancock WW, Becker GJ, Atkins RC. A comparison of fixatives and immunohistochemical technics for use with monoclonal antibodies to cell surface antigens. Am J Clin Pathol 1982; 78: 825.
23. Fuggle SV, McWhinnie DL, Chapman JR, Taylor HM, Morris PJ. Sequential analysis of HLA-class II antigen expression in human renal allografts. Transplantation 1986; 42: 144.
24. Miossec P, Cavender D, Ziff M. Production of interleukin 1 by human endothelial cells. J Immunol 1986; 136: 2486.
25. Libby P, Ordovas JM, Auger KR, Robbins AH, Birinyi LK, Dinarello CA. Endotoxin and tumor necrosis factor induce interleukin- 1 gene expression in adult human vascular endothelial cells. Am J Pathol 1986; 124: 179.
26. Miossec P, Cavender D, Ziff M. Interleukin 1 derived from human endothelial cells enhances the binding and chemotactic step of T lymphocyte emigration. Clin Exp Immunol 1988; 73: 250.
27. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 1985; 76: 2003.
28. Schleimer RP, Rutledge BK. Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. J Immunol 1986; 136: 649.
29. Fuggle SV, Errasti P, Daar AS, Fabre JW, Ting A, Morris PJ. Localization of major histocompatibility complex (HLA-ABC and DR) antigens in 46 kidneys. Transplantation 1983; 35: 385.
30. Simpson PJ, Todd RF III, Fantone JC, et al. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mol, anti-CDllb) that inhibits leukocyte adhesion. J Clin Invest 1988; 81: 624.